Immunotherapy drug Keytruda received FDA approval and showed benefit for treatment of colorectal cancer
Full article:

In June 2020, the FDA approved Keytruda (pembrolizumab) as an initial therapy for advanced colorectal cancer. This approval was based on the results from the KEYNOTE-177 study. In this study, Keytruda was more successful than chemotherapy in delaying progression of certain types of colorectal cancers. (11/25/20)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies enrolling people with advanced colorectal cancer.  

A number of other clinical trials for patients with colorectal cancer can be found here.


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.